Phone: 267-687-0620 Fax: 215-253-4110
CGx testing determines a patient’s risk for hereditary cancers.
Lehigh Valley Genomics runs a panel of 45 genes suspected to play a role in predisposing patients to cancer, including genes associated with common and rare cancers.
A person with an inherited gene mutation will not necessarily develop cancer, but he or she will be at a higher risk.
Breast | Ovarian | Endometrial | Colorectal | Gastric | Prostate | Pancreatic | Melanoma